Analgesics in Japan

Product Code EUR00660
Publication Date July 2011
Publisher Euromonitor
Product Type Report
Pages 37
ISBN Number not applicable
Change currency
PDF £675.00 €813 $1,067 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Analgesics in Japan

Analgesics suffered a decline in sales in 2010, mainly for three reasons. Firstly, the decline represented a rebound from the strong demand related to the flu outbreak in 2009. Secondly, the revised Pharmaceutical Affairs Law, which limited Class 1 product sales to certain outlets with pharmacists, had a negative impact. Thirdly, there was a lack of new product launches to give dynamism to the category.

Euromonitor International's Analgesics in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

  • Analgesics in Japan
  • Euromonitor International
  • July 2011
  • List of Contents and Headlines
    • Trends
    • Switches
    • Competitive Landscape
    • Prospects
    • Category Data
    • Daiichi Sankyo Healthcare Co Ltd in Consumer Health (japan)
    • Strategic Direction
    • Key Facts
  • Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
  • Summary 2 Daiichi Sankyo Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2010
    • Hisamitsu Pharmaceutical Co Inc in Consumer Health (japan)
    • Strategic Direction
    • Key Facts
  • Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
  • Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2010
    • Kobayashi Pharmaceutical Co Ltd in Consumer Health (japan)
    • Strategic Direction
    • Key Facts
  • Summary 7 Kobayashi Pharmaceutical Co Ltd: Key Facts
  • Summary 8 Kobayashi Pharmaceutical Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 9 Kobayashi Pharmaceutical Co Ltd: Competitive Position 2010
    • Sato Pharmaceutical Co Ltd in Consumer Health (japan)
    • Strategic Direction
    • Key Facts
  • Summary 10 Sato Pharmaceutical Co Ltd: Key Facts
  • Summary 11 Sato Pharmaceutical Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 12 Sato Pharmaceutical Co Ltd: Competitive Position 2010
    • Ssp Co Ltd in Consumer Health (japan)
    • Strategic Direction
    • Key Facts
  • Summary 13 SSP Co Ltd: Key Facts
  • Summary 14 SSP Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 15 SSP Co Ltd: Competitive Position 2010
    • Taisho Pharmaceutical Co Ltd in Consumer Health (japan)
    • Strategic Direction
    • Key Facts
  • Summary 16 Taisho Pharmaceutical Co Ltd: Key Facts
  • Summary 17 Taisho Pharmaceutical Co Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 18 Taisho Pharmaceutical Co Ltd: Competitive Position 2010
    • Takeda Chemical Industries Ltd in Consumer Health (japan)
    • Strategic Direction
    • Key Facts
  • Summary 19 Takeda Chemical Industries Ltd: Key Facts
  • Summary 20 Takeda Chemical Industries Ltd: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 21 Takeda Chemical Industries Ltd: Competitive Position 2010
    • Executive Summary
    • Slow But Steady Recovery From Revised Pal Implementation
    • Consumers Focus on Health Maintenance Rather Than Cure
    • Competitive Environment Remained Stagnant
    • Revised Pal Makes Only Small Impact on Retail Landscape
    • Positive But Slower Growth Expected Over the Forecast Period
    • Key Trends and Developments
    • Adding Value Through New Formats and Convenience
    • Desire for Healthy and Beautiful Living Continues
    • Promoting Active Ageing
    • Revised Pal Plan To Broaden Sales Channels A Flop
    • Lack of Pharmacists Dampens Sales of Switched OTC Products
    • Market Indicators
    • Market Data
    • Consumer Healthcare Registration and Classification
    • Self-medication/self-care and Preventative Medicine
    • Switches
  • Summary 22 OTC Healthcare Switches 2008-2010
    • Definitions
  • Summary 23 Research Sources
  • List of Tables
    • Table 1 Sales of Analgesics by Category: Value 2005-2010
    • Table 2 Sales of Analgesics by Category: % Value Growth 2005-2010
    • Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
    • Table 4 Analgesics Company Shares by Value 2006-2010
    • Table 5 Analgesics Brand Shares by Value 2007-2010
    • Table 6 Forecast Sales of Analgesics by Category: Value 2010-2015
    • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015
    • Table 8 Consumer Expenditure on Health Goods and Medical Services 2005-2010
    • Table 9 Life Expectancy at Birth 2005-2010
    • Table 10 Sales of Consumer Health by Category: Value 2005-2010
    • Table 11 Sales of Consumer Health by Category: % Value Growth 2005-2010
    • Table 12 Consumer Health Company Shares by Value 2006-2010
    • Table 13 Consumer Health Brand Shares by Value 2007-2010
    • Table 14 Penetration of Private Label by Category 2005-2010
    • Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
    • Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
    • Table 17 Forecast Sales of Consumer Health by Category: Value 2010-2015
    • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015